Featured

AUDIO: What COA said about the application in 2019 to FDA for clinical trials of COA 72 as an anti-HIV drug

When the Parliamentary Select Committee on Health visited and what COA said about the application in 2019 to FDA for clinical trials of COA 72 as an anti-HIV drug in 2019 and the payment of $5000 registration.

Dr Caleb Mawuli Agbale, the Product Manager briefed the committee members on the operations of COA and the product.

Connect With Us : 0242202447 | 0551484843 | 0266361755 | 059 199 7513 |